Article Details

Fierce Pharma Asia—AstraZeneca's China growth; Takeda's $3.5B neuro pact; Biocon, Viatris ...

Retrieved on: 2021-07-30 15:11:15

Tags for this article:

Click the tags to see associated articles and topics

Fierce Pharma Asia—AstraZeneca's China growth; Takeda's $3.5B neuro pact; Biocon, Viatris .... View article details on HISWAI: https://www.fiercepharma.com/pharma-asia/fierce-pharma-asia-astrazeneca-s-china-growth-takeda-s-cns-pact-biocon-viatris-historic

Excerpt

General Catalyst led the round with participation from existing shareholders Rakuten Group and SBI Group. The company develops drugs based on its ...

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up